Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial
2016
Background
To provide evidence that the Chinese herbal medicine (CHM) PSORI-CM01 combined with Western medicine reduces the relapse rate of psoriasis vulgaris (PV), we plan to conduct a large-scale randomized control trial (RCT). In order to improve and perfect the RCT, this pilot study was designed to determine the feasibility and the potential of a modified protocol for the full-scale RCT.
Keywords:
- Physical therapy
- Medicine
- Psoriasis
- Betamethasone
- Alternative medicine
- Randomized controlled trial
- Severity of illness
- Young adult
- PSORI-CM01
- Internal medicine
- Placebo-controlled study
- Quality of life
- Clinical trial
- Traditional medicine
- Placebo
- Body surface area
- Dermatology Life Quality Index
- Psoriasis Area and Severity Index
- Visual analogue scale
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
20
References
12
Citations
NaN
KQI